Tranche Update on Kukje Pharmaceutical Industrial Co. Ltd.'s Equity Buyback Plan announced on November 2, 2016.
January 12, 2017
Share
From November 2, 2016 to January 10, 2017, the company has repurchased 300,000 shares, representing 1.81% for KRW 1,371.73 million. With this, the company has completed the repurchase of 300,000 shares, representing 1.81% for KRW 1,371.73 million under the buyback announced on November 2, 2016.
Kukje Pharma Co., Ltd, formerly Kukje Pharma Ind. Co., Ltd, is a Korea-based company engaged in the manufacture of pharmaceuticals. The Companyâs products are finished products, such as antibiotics, other antibiotics for injection, antifungal and antiviral agents, agents for gastrointestinal tract and liver, muscle relaxants, anti-osteoporotics, corticosteroids, agents for cardiovascular and endocrine systems, ophthalmic agents, remedies for central nervous system (CNS) disorders, remedies for urinary systems, antihistamines, antitussives, cough and cold remedies, non-steroidal anti inflammatory drugs (NSAIDs), antitussive, cough and cold remedies, as well as other over-the-counter (OTC) drugs. It also provides raw materials, such as ceftriaxone sodium sterile, cefuroxime axetil, ceftezole sodium sterile, cefminox sodium sterile, cefuroxime sodium sterile and others.
KUKJE PHARMA CO., LTD. 
